Alerts will be sent to your verified email
Verify EmailSANJIVIN
Sanjivani Paranteral
|
Kimia Biosciences
|
Ambalal Sarabhai Ent
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Quarterly Sales Volume - Injectables
|
n/a | n/a | n/a |
Quarterly Sales Volume - Orals
|
n/a | n/a | n/a |
Quarterly Sales Volume - Nutraceuticals
|
n/a | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
-37.68 % | -352.38 % | 19.11 % |
5yr average Equity Multiplier
|
-1.69 | 65.1 | 2.07 |
5yr Average Asset Turnover Ratio
|
1.39 | 1.17 | 0.75 |
5yr Avg Net Profit Margin
|
7.02 % | -2.03 % | 10.89 % |
Price to Book
|
6.84 | 0.0 | 1.81 |
P/E
|
32.14 | 27.34 | 51.24 |
5yr Avg Cash Conversion Cycle
|
-55.03 Days | 28.76 Days | -37.53 Days |
Inventory Days
|
28.68 Days | 94.07 Days | 33.51 Days |
Days Receivable
|
21.4 Days | 101.18 Days | 63.69 Days |
Days Payable
|
284.6 Days | 144.79 Days | 147.98 Days |
5yr Average Interest Coverage Ratio
|
15.99 | 0.28 | 9.88 |
5yr Avg ROCE
|
-87.74 % | -0.98 % | 24.01 % |
5yr Avg Operating Profit Margin
|
9.71 % | 1.32 % | 5.29 % |
5 yr average Debt to Equity
|
-0.72 | 29.7 | 0.32 |
5yr CAGR Net Profit
|
n/a | n/a | -30.01 % |
5yr Average Return on Assets
|
11.72 % | -2.12 % | 8.69 % |
Shareholdings
|
|||
Promoter Holding
|
28.87 % | 74.94 % | 31.35 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.52 % | 0.0 | 0.59 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Sanjivani Paranteral
|
Kimia Biosciences
|
Ambalal Sarabhai Ent
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|